Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations

Smrithi Salian, Tae Joon Cho, Shubha R. Phadke, Kalpana Gowrishankar, Gandham Sri Lakshmi Bhavani, Anju Shukla, Sujatha Jagadeesh, Ok Hwa Kim, Gen Nishimura, Katta M. Girisha

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Smith-McCort dysplasia (SMC OMIM 615222) and Dyggve-Melchior-Clausen dysplasia (DMC OMIM 223800) are allelic skeletal dysplasias caused by homozygous or compound heterozygous mutations in DYM (OMIM 607461). Both disorders share the same skeletal phenotypes characterized by spondylo-epi-metaphyseal dysplasia with distinctive lacy ilia. The difference rests on the presence or absence of intellectual disability, that is, intellectual disability in DMC and normal cognition in SMC. However, genetic heterogeneity was suspected in SMC. Recently, RAB33B (OMIM 605950) has been identified as the second gene for SMC. Nevertheless, only two affected families have been reported so far. Here we present three SMC patients with four novel pathogenic variants in RAB33B, including homozygosity for c.211C>T (p.R71*), homozygosity for c.365T>C (p.F122S), and compound heterozygosity for c.48delCGGGGCAG (p.G17Vfs*58) and c.490C>T (p.Q164*). We also summarize the clinical, radiological, and mutation profile of RAB33B after literature mining. This report ascertains the pathogenic relationship between RAB33B and SMC.

Original languageEnglish
Pages (from-to)588-595
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume173
Issue number3
DOIs
Publication statusPublished - 01-03-2017

Fingerprint

Genetic Databases
Mutation
Intellectual Disability
Ilium
Genetic Heterogeneity
Cognition
Phenotype
Smith-McCort Dysplasia
Genes

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Salian, Smrithi ; Cho, Tae Joon ; Phadke, Shubha R. ; Gowrishankar, Kalpana ; Bhavani, Gandham Sri Lakshmi ; Shukla, Anju ; Jagadeesh, Sujatha ; Kim, Ok Hwa ; Nishimura, Gen ; Girisha, Katta M. / Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations. In: American Journal of Medical Genetics, Part A. 2017 ; Vol. 173, No. 3. pp. 588-595.
@article{1d4e21ce2198484a8eb264b94eed91f9,
title = "Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations",
abstract = "Smith-McCort dysplasia (SMC OMIM 615222) and Dyggve-Melchior-Clausen dysplasia (DMC OMIM 223800) are allelic skeletal dysplasias caused by homozygous or compound heterozygous mutations in DYM (OMIM 607461). Both disorders share the same skeletal phenotypes characterized by spondylo-epi-metaphyseal dysplasia with distinctive lacy ilia. The difference rests on the presence or absence of intellectual disability, that is, intellectual disability in DMC and normal cognition in SMC. However, genetic heterogeneity was suspected in SMC. Recently, RAB33B (OMIM 605950) has been identified as the second gene for SMC. Nevertheless, only two affected families have been reported so far. Here we present three SMC patients with four novel pathogenic variants in RAB33B, including homozygosity for c.211C>T (p.R71*), homozygosity for c.365T>C (p.F122S), and compound heterozygosity for c.48delCGGGGCAG (p.G17Vfs*58) and c.490C>T (p.Q164*). We also summarize the clinical, radiological, and mutation profile of RAB33B after literature mining. This report ascertains the pathogenic relationship between RAB33B and SMC.",
author = "Smrithi Salian and Cho, {Tae Joon} and Phadke, {Shubha R.} and Kalpana Gowrishankar and Bhavani, {Gandham Sri Lakshmi} and Anju Shukla and Sujatha Jagadeesh and Kim, {Ok Hwa} and Gen Nishimura and Girisha, {Katta M.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/ajmg.a.38064",
language = "English",
volume = "173",
pages = "588--595",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

Salian, S, Cho, TJ, Phadke, SR, Gowrishankar, K, Bhavani, GSL, Shukla, A, Jagadeesh, S, Kim, OH, Nishimura, G & Girisha, KM 2017, 'Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations', American Journal of Medical Genetics, Part A, vol. 173, no. 3, pp. 588-595. https://doi.org/10.1002/ajmg.a.38064

Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations. / Salian, Smrithi; Cho, Tae Joon; Phadke, Shubha R.; Gowrishankar, Kalpana; Bhavani, Gandham Sri Lakshmi; Shukla, Anju; Jagadeesh, Sujatha; Kim, Ok Hwa; Nishimura, Gen; Girisha, Katta M.

In: American Journal of Medical Genetics, Part A, Vol. 173, No. 3, 01.03.2017, p. 588-595.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Additional three patients with Smith-McCort dysplasia due to novel RAB33B mutations

AU - Salian, Smrithi

AU - Cho, Tae Joon

AU - Phadke, Shubha R.

AU - Gowrishankar, Kalpana

AU - Bhavani, Gandham Sri Lakshmi

AU - Shukla, Anju

AU - Jagadeesh, Sujatha

AU - Kim, Ok Hwa

AU - Nishimura, Gen

AU - Girisha, Katta M.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Smith-McCort dysplasia (SMC OMIM 615222) and Dyggve-Melchior-Clausen dysplasia (DMC OMIM 223800) are allelic skeletal dysplasias caused by homozygous or compound heterozygous mutations in DYM (OMIM 607461). Both disorders share the same skeletal phenotypes characterized by spondylo-epi-metaphyseal dysplasia with distinctive lacy ilia. The difference rests on the presence or absence of intellectual disability, that is, intellectual disability in DMC and normal cognition in SMC. However, genetic heterogeneity was suspected in SMC. Recently, RAB33B (OMIM 605950) has been identified as the second gene for SMC. Nevertheless, only two affected families have been reported so far. Here we present three SMC patients with four novel pathogenic variants in RAB33B, including homozygosity for c.211C>T (p.R71*), homozygosity for c.365T>C (p.F122S), and compound heterozygosity for c.48delCGGGGCAG (p.G17Vfs*58) and c.490C>T (p.Q164*). We also summarize the clinical, radiological, and mutation profile of RAB33B after literature mining. This report ascertains the pathogenic relationship between RAB33B and SMC.

AB - Smith-McCort dysplasia (SMC OMIM 615222) and Dyggve-Melchior-Clausen dysplasia (DMC OMIM 223800) are allelic skeletal dysplasias caused by homozygous or compound heterozygous mutations in DYM (OMIM 607461). Both disorders share the same skeletal phenotypes characterized by spondylo-epi-metaphyseal dysplasia with distinctive lacy ilia. The difference rests on the presence or absence of intellectual disability, that is, intellectual disability in DMC and normal cognition in SMC. However, genetic heterogeneity was suspected in SMC. Recently, RAB33B (OMIM 605950) has been identified as the second gene for SMC. Nevertheless, only two affected families have been reported so far. Here we present three SMC patients with four novel pathogenic variants in RAB33B, including homozygosity for c.211C>T (p.R71*), homozygosity for c.365T>C (p.F122S), and compound heterozygosity for c.48delCGGGGCAG (p.G17Vfs*58) and c.490C>T (p.Q164*). We also summarize the clinical, radiological, and mutation profile of RAB33B after literature mining. This report ascertains the pathogenic relationship between RAB33B and SMC.

UR - http://www.scopus.com/inward/record.url?scp=85011382789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011382789&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.38064

DO - 10.1002/ajmg.a.38064

M3 - Article

VL - 173

SP - 588

EP - 595

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -